{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:41:37Z","timestamp":1786736497157,"version":"build-2736575974"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pathol Microbiol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijpm.ijpm_877_19","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T03:44:27Z","timestamp":1582688667000},"page":"7","source":"Crossref","is-referenced-by-count":5,"title":["Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses"],"prefix":"10.4103","volume":"63","author":[{"given":"MukulK","family":"Divatia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"El-Zaatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0377-4929.279553-1","unstructured":"Fleming S, Amin MB, Storkel S. Collecting duct carcinoma. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO Classification of Tumours ofthe Urinary System and Male Genital Organs. 4th ed., vol. 8. Lyon, France: IARC Press World Health Organization Classification of Tumours; 2016. p. 29-30."},{"key":"key-10.4103\/0377-4929.279553-2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/0001555553409416","article-title":"Cutaneous leiomyomata with uterine leiomyomata","author":"Reed","year":"1973","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0377-4929.279553-3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jmg.2005.036400","article-title":"Increased risk of cancer in patients with fumarate hydratase germline mutation","author":"Lehtonen","year":"2006","journal-title":"J Med Genet"},{"key":"key-10.4103\/0377-4929.279553-4","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.5858\/arpa.2016-0218-RA","article-title":"Morphologic, molecular, and taxonomic evolution of renal Cell carcinoma: A conceptual perspective with emphasis on updates to the 2016 World Health Organization Classification","author":"Udager","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"key-10.4103\/0377-4929.279553-5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","article-title":"Hereditary leiomyomatosis and renal cell cancer: Update on clinical and molecular characteristics","author":"Lehtonen","year":"2011","journal-title":"Fam Cancer"},{"key":"key-10.4103\/0377-4929.279553-6","first-page":"406","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"key-10.4103\/0377-4929.279553-7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC): Renal cancer risk, surveillance and treatment","author":"Menko","year":"2014","journal-title":"Fam Cancer"},{"key":"key-10.4103\/0377-4929.279553-8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/PAS.0000000000001000","article-title":"Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate hydratase-deficient renal cell carcinoma","author":"Ohe","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-9","first-page":"199","article-title":"Clinical features of multiple cutaneous and uterine leiomyomatosis: An underdiagnosed tumor syndrome","author":"Alam","year":"2005","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0377-4929.279553-10","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0377-4929.279553-11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"key-10.4103\/0377-4929.279553-12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-13","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","article-title":"Hereditary leiomyomatosis and renal cell cancer: A syndrome associated with an aggressive form of inherited renal cancer","author":"Grubb","year":"2007","journal-title":"J Urol"},{"key":"key-10.4103\/0377-4929.279553-14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jmg.2010.085068","article-title":"Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma","author":"Gardie","year":"2011","journal-title":"J Med Genet"},{"key":"key-10.4103\/0377-4929.279553-15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2350-9-20","article-title":"The FH mutation database: An online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency","author":"Bayley","year":"2008","journal-title":"BMC Med Genet"},{"key":"key-10.4103\/0377-4929.279553-16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAP.0b013e31820cb3dd","article-title":"Differential diagnosis of renal tumors with papillary architecture","author":"Tickoo","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"key-10.4103\/0377-4929.279553-17","first-page":"123","article-title":"Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: Implications for surveillance","author":"van","year":"2012","journal-title":"Fam Cancer"},{"key":"key-10.4103\/0377-4929.279553-18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","article-title":"Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis","author":"Smit","year":"2011","journal-title":"Clin Genet"},{"key":"key-10.4103\/0377-4929.279553-19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MOU.0000000000000094","article-title":"Nephron-sparing surgery for multifocal and hereditary renal tumors","author":"Metwalli","year":"2014","journal-title":"Curr Opin Urol"},{"key":"key-10.4103\/0377-4929.279553-20","first-page":"1584","article-title":"Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer","author":"Stewart","year":"2008","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0377-4929.279553-21","first-page":"335","article-title":"Cutaneous leiomyomas: A clinical marker of risk for hereditary leiomyomatosis and renal cell cancer","author":"Stewart","year":"2006","journal-title":"Dermatol Nurs"},{"key":"key-10.4103\/0377-4929.279553-22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-4632.2011.05456.x","article-title":"Multiple cutaneous and uterine leiomyomatosis in a 36-year-old female, and discussion of hereditary leiomyomatosis and renal cell carcinoma","author":"Henley","year":"2012","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0377-4929.279553-23","first-page":"18","article-title":"Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer","author":"Wei","year":"2006","journal-title":"J Med Genet"},{"key":"key-10.4103\/0377-4929.279553-24","first-page":"1","article-title":"Hysterectomysurveillance-United States, 1994-1999","author":"Keshavarz","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.4103\/0377-4929.279553-25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/PAS.0b013e318223ca01","article-title":"Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: A case report","author":"Garg","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-26","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/PAS.0000000000000520","article-title":"Morphology and Immunohistochemistry for 2SC and FH Aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients","author":"Joseph","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/modpathol.2013.215","article-title":"Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: Detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry","author":"Reyes","year":"2014","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.279553-28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PAS.0b013e31825ec16f","article-title":"Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome","author":"Sanz-Ortega","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ijc.21798","article-title":"Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients","author":"Ylisaukko-oja","year":"2006","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0377-4929.279553-30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","author":"Shuch","year":"2013","journal-title":"J Urol"},{"key":"key-10.4103\/0377-4929.279553-31","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: A clinical and molecular genetic investigation","author":"Matyakhina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0377-4929.279553-32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2017.10.013","article-title":"The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes","author":"Udager","year":"2018","journal-title":"Hum Pathol"},{"key":"key-10.4103\/0377-4929.279553-33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/RLU.0000000000001760","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome combined with adrenocortical carcinoma on 18F-FDG PET\/CT","author":"Guo","year":"2017","journal-title":"Clin Nucl Med"},{"key":"key-10.4103\/0377-4929.279553-34","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1210\/jc.2006-0183","article-title":"Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations","author":"Carvajal-Carmona","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0377-4929.279553-35","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","article-title":"Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency","author":"Alam","year":"2003","journal-title":"Hum Mol Genet"},{"key":"key-10.4103\/0377-4929.279553-36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/PAS.0000000000000127","article-title":"Hereditary leiomyomatosis and renal cell carcinoma (HLRCC): A rapid autopsy report of metastatic renal cell carcinoma","author":"Udager","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: Recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-38","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: A frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma","author":"Smith","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/his.13183","article-title":"A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma","author":"Smith","year":"2017","journal-title":"Histopathology"},{"key":"key-10.4103\/0377-4929.279553-40","unstructured":"Muller M, Guillaud-Bataille M, Salleron J, Genestie C, Deveaux S,"},{"key":"key-10.4103\/0377-4929.279553-41","first-page":"974","article-title":"Pattern multiplicity and fumarate hydratase (FH)\/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration","author":"Slama","year":"2018","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.279553-42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccr.2007.02.005","article-title":"Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway","author":"Pollard","year":"2007","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0377-4929.279553-43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/PAS.0000000000000840","article-title":"Immunohistochemical characterization of Fumarate Hydratase (FH) and Succinate Dehydrogenase (SDH) in cutaneous leiomyomas for detection of familial cancer syndromes","author":"Carter","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-45","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/DAD.0000000000000580","article-title":"Loss of fumarate hydratase and aberrant protein succination detected with S-(2-Succino)-cysteine staining to identify patients with multiple cutaneous and uterine leiomyomatosis and hereditary leiomyomatosis and renal cell cancer syndrome","author":"Llamas-Velasco","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"key-10.4103\/0377-4929.279553-46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/PAS.0000000000000626","article-title":"Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in cutaneous leiomyomas may aid in identification of patients with hlrcc (hereditary leiomyomatosis and renal cell carcinoma syndrome)","author":"Buelow","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability","author":"Isaacs","year":"2005","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0377-4929.279553-49","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","author":"Pollard","year":"2005","journal-title":"Hum Mol Genet"},{"key":"key-10.4103\/0377-4929.279553-50","first-page":"85","article-title":"The emerging role of fumarate as an oncometabolite","author":"Yang","year":"2012","journal-title":"Front Oncol"},{"key":"key-10.4103\/0377-4929.279553-51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","author":"Bardella","year":"2011","journal-title":"J Pathol"},{"key":"key-10.4103\/0377-4929.279553-52","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: Roles for fumarate in KEAP1 succination and Nrf2 signaling","author":"Adam","year":"2011","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0377-4929.279553-53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ccr.2011.08.024","article-title":"An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma","author":"Ooi","year":"2011","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0377-4929.279553-54","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","author":"Chen","year":"2016","journal-title":"Cell Rep"},{"key":"key-10.4103\/0377-4929.279553-55","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","author":"Xiao","year":"2012","journal-title":"Genes Dev"},{"key":"key-10.4103\/0377-4929.279553-56","first-page":"537","article-title":"Papillary renal cell carcinoma: A clinicopathologic and immunohistochemical study of 105 tumors","author":"Delahunt","year":"1997","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.279553-57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00000478-200203000-00001","article-title":"Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases","author":"Amin","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.juro.2011.09.053","article-title":"Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma","author":"Sukov","year":"2012","journal-title":"J Urol"},{"key":"key-10.4103\/0377-4929.279553-59","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.humpath.2014.02.004","article-title":"Papillary renal cell carcinoma revisited: A comprehensive histomorphologic study with outcome correlations","author":"Warrick","year":"2014","journal-title":"Hum Pathol"},{"key":"key-10.4103\/0377-4929.279553-60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-5347(05)64830-6","article-title":"Biological significance of c-met over expression in papillary renal cell carcinoma","author":"Sweeney","year":"2002","journal-title":"J Urol"},{"key":"key-10.4103\/0377-4929.279553-61","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/PAS.0b013e3182635954","article-title":"Carcinoma of the collecting ducts of bellini and renal medullary carcinoma: Clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship","author":"Gupta","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0046-8177(90)90209-N","article-title":"Collecting duct carcinoma of the kidney","author":"Kennedy","year":"1990","journal-title":"Hum Pathol"},{"key":"key-10.4103\/0377-4929.279553-63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(06)00502-7","article-title":"Collecting duct (Bellini duct) renal cell carcinoma: A nationwide survey in Japan","author":"Tokuda","year":"2006","journal-title":"J Urol"},{"key":"key-10.4103\/0377-4929.279553-64","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/PAS.0b013e3181dc5e8a","article-title":"PAX8 (+)\/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): A useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract","author":"Albadine","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-65","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.humpath.2013.07.006","article-title":"The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas","author":"Gonzalez-Roibon","year":"2013","journal-title":"Hum Pathol"},{"key":"key-10.4103\/0377-4929.279553-66","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/modpathol.2009.88","article-title":"Expression of PAX8 in normal and neoplastic renal tissues: An immunohistochemical study","author":"Tong","year":"2009","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.279553-67","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.humpath.2007.11.020","article-title":"Collecting duct carcinoma of the kidney: An immunohistochemical evaluation of the use of antibodies for differential diagnosis","author":"Kobayashi","year":"2008","journal-title":"Hum Pathol"},{"key":"key-10.4103\/0377-4929.279553-68","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eururo.2015.06.019","article-title":"Characterization of clinical cases of collecting duct carcinoma of the kidney assessed by comprehensive genomic profiling","author":"Pal","year":"2016","journal-title":"Eur Urol"},{"key":"key-10.4103\/0377-4929.279553-69","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-70","first-page":"43","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","author":"Cancer","year":"2013","journal-title":"Nature"},{"key":"key-10.4103\/0377-4929.279553-71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"key-10.4103\/0377-4929.279553-72","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/00000478-200212000-00003","article-title":"PRCC-TFE3 renal carcinomas: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X; 1)(p11.2;q21)","author":"Argani","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-73","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/PAS.0b013e318031ffff","article-title":"Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum","author":"Argani","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-74","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/PAS.0b013e31824f24a6","article-title":"Translocation renal cell carcinomas in adults: A single-institution experience","author":"Zhong","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-75","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","article-title":"TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-76","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/PAS.0b013e31827e17cb","article-title":"TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: Expanding the morphologic spectrum","author":"Rao","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-77","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/PAS.0b013e31828a69ae","article-title":"Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service","author":"Green","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000776","article-title":"Renal cell carcinoma with chromosome 6p amplification including the TFEB gene: A novel mechanism of tumor pathogenesis?","author":"Williamson","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-79","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-amplified Renal cell carcinomas: An aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-80","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.2017.24","article-title":"TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: A distinct entity with potential implications for clinical management","author":"Gupta","year":"2017","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.279553-81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/modpathol.2017.99","article-title":"Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: Systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays","author":"Skala","year":"2018","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.279553-82","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/PAS.0b013e31824dd972","article-title":"TFE3 rearrangements in adult renal cell carcinoma: Clinical and pathologic features with outcome in a large series of consecutively treated patients","author":"Sukov","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-83","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia","author":"Srigley","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0377-4929.279553-84","first-page":"11124","article-title":"Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: Clinicopathologic study of two cases and review of the literature","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key-10.4103\/0377-4929.279553-85","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2014.86","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: Detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma","author":"Williamson","year":"2015","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.279553-86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/his.13362","article-title":"Morphological spectrum of renal cell carcinoma, unclassified: An analysis of 136 cases","author":"Perrino","year":"2018","journal-title":"Histopathology"},{"key":"key-10.4103\/0377-4929.279553-87","doi-asserted-by":"crossref","first-page":"13131","DOI":"10.1038\/ncomms13131","article-title":"Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"key":"key-10.4103\/0377-4929.279553-88","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.eururo.2012.02.039","article-title":"Systematic review of oncological outcomes following surgical management of localised renal cancer","author":"MacLennan","year":"2012","journal-title":"Eur Urol"},{"key":"key-10.4103\/0377-4929.279553-89","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: A metabolic disease","author":"Linehan","year":"2010","journal-title":"Nat Rev Urol"},{"key":"key-10.4103\/0377-4929.279553-90","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1101\/gr.131110.111","article-title":"Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics","author":"Linehan","year":"2012","journal-title":"Genome Res"},{"key":"key-10.4103\/0377-4929.279553-91","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrurol.2010.234","article-title":"Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC","author":"Yamasaki","year":"2011","journal-title":"Nat Rev Urol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:42:41Z","timestamp":1786732961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_877_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":91,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"alternative-id":["279553"],"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_877_19","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}